Investigation of plasma metabolomics and neurotransmitter dysfunction in the process of Alzheimer's disease rat induced by amyloid beta 25-35

被引:5
|
作者
Wei, Mengying [1 ,2 ]
Liu, Yuanyuan [1 ]
Pi, Zifeng [2 ]
Yue, Kexin [1 ]
Li, Shizhe [3 ]
Hu, Mingxin [1 ]
Liu, Zhiqiang [2 ]
Song, Fengrui [2 ]
Liu, Zhongying [1 ]
机构
[1] Jilin Univ, Sch Pharmaceut Sci, 1266 Fujin Rd, Changchun 130021, Jilin, Peoples R China
[2] Chinese Acad Sci, Changchun Inst Appl Chem, Natl Ctr Mass Spectrometry Changchun, Jilin Prov Key Lab Chinese Med Chem & Mass Spectr, Changchun 130022, Jilin, Peoples R China
[3] Guangdong Univ Technol, Inst Biomed & Pharmaceut Sci, Guangzhou 510006, Guangdong, Peoples R China
基金
中国国家自然科学基金;
关键词
ARACHIDONIC-ACID; NITRIC-OXIDE; FATTY-ACIDS; DEMENTIA; SYSTEMS; CHOLESTEROL; NEUROINFLAMMATION; HOMOCYSTEINE; INFLAMMATION; HIPPOCAMPUS;
D O I
10.1039/c9ra00302a
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Alzheimer's disease (AD) has become one of the major diseases endangering the health of the elderly. Clarifying the features of each AD animal model is valuable for understanding the onset and progression of diseases and developing potential treatments in the pharmaceutical industry. In this study, we aimed to clarify plasma metabolomics and neurotransmitter dysfunction in the process of AD model rat induced by amyloid beta 25-35 (A beta 25-35). Firstly, Morris Water Maze (MWM) test was used to investigate cognitive impairment in AD rat after 2, 4 and 8 weeks of modelling. Based on this, the effects on levels of AD-related enzymes and eight neurotransmitters were analyzed. And plasma metabolomics analysis based on ultra high-performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry (UHPLC-Q-TOF-MS) was used to research the metabolic disturbances in the process of AD rat. The results shown the injury on the spatial learning ability of AD rats was gradually aggravated within 4 weeks, reached the maximum at 4 weeks and then was stable until 8 weeks. During 8 weeks of modeling, the levels of enzymes including beta-secretase, gamma-secretase, glycogen synthase kinase-3 beta (GSK-3 beta), acetyl cholinesterase (AchE) and nitric oxide synthase (NOS) were significant increased in the plasma of AD rats. The neurotransmitter dysfunction was mainly involved in gamma-aminobutyric acid (GABA), acetyl choline (Ach), glutamic acid (Glu), 5-hydroxytryptamine (5-HT), dopamine (DA) and norepinephrine (NE). 17 endogenous metabolites correlated with AD were successfully detected in the metabolomics analysis. These metabolites were mainly involved in fatty acids, sphingolipids, and sterols metabolisms, vitamin metabolism, and amino acid metabolism. These metabolites might be the potential biomarkers that correctly mark different stages of AD. The study on peripheral plasma indices reflecting the process of AD laid the foundation for understand the pathophysiology of AD and find an effective and radical cure. And the rules of endogenous metabolic disorder in AD rats also have a certain guiding significance for the future study of food-drug interactions at different stages of AD.
引用
收藏
页码:18308 / 18319
页数:12
相关论文
共 50 条
  • [21] Effect of adrenalectomy on nucleus Meynert neurons in amyloid-β 25-35 peptide-induced model of Alzheimer's disease
    Simonyan, K.
    Mnatsakanyan, V.
    Stepanyan, H.
    Chavushyan, V.
    Meliksetyan, I.
    Avetisyan, Z.
    Mnatsakanyan, H.
    JOURNAL OF NEUROLOGY, 2010, 257 : S64 - S64
  • [22] Icariin inhibits beta-amyloid peptide segment 25-35 induced expression of β-secretase in rat hippocampus
    Nie, Jing
    Luo, Yong
    Huang, Xie-Nan
    Gong, Qi-Hai
    Wu, Qin
    Shi, Jing-Shan
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2010, 626 (2-3) : 213 - 218
  • [23] Antidepressant-Like Effect of RoprenA® in β-Amyloid-(25-35) Rat Model of Alzheimer's Disease with Altered Levels of Androgens
    Soultanov, Vagif
    Fedotova, Julia
    Nikitina, Tamara
    Roschin, Victor
    Ordyan, Natalia
    Hritcu, Lucian
    MOLECULAR NEUROBIOLOGY, 2017, 54 (04) : 2611 - 2621
  • [24] Effects of pyrrolidine dithiocarbamate on beta-amyloid (25-35)-induced inflammatory responses and memory deficits in the rat
    Cheng, Guanliang
    Whitehead, Shawn N.
    Hachinski, Vladimir
    Cechetto, David F.
    NEUROBIOLOGY OF DISEASE, 2006, 23 (01) : 140 - 151
  • [25] REVERSIBLE RANDOM COIL BETA-SHEET TRANSITION OF THE ALZHEIMER BETA-AMYLOID FRAGMENT (25-35)
    TERZI, E
    HOLZEMANN, G
    SEELIG, J
    BIOCHEMISTRY, 1994, 33 (06) : 1345 - 1350
  • [26] Effect of Indigofera tinctoria on β-amyloid (25-35) mediated Alzheimer's disease in mice: Relationship to antioxidant activity
    Balamurugan, G.
    Muralidharan, P.
    BANGLADESH JOURNAL OF PHARMACOLOGY, 2010, 5 (01) : 51 - 56
  • [27] Effect of Hesperidin Extraction on Cell Proliferation and Apoptosis of Alzheimer's Disease Induced by Aβ25-35
    Luo, Xiaoting
    Huang, Qin
    Li, Shumei
    Li, Sisi
    Xiong, Liang
    Dong, Minghua
    2010 3RD INTERNATIONAL CONFERENCE ON BIOMEDICAL ENGINEERING AND INFORMATICS (BMEI 2010), VOLS 1-7, 2010, : 2020 - 2023
  • [28] Characterization of Changes due to pH Variations in Beta Peptide (25-35) Leading to Alzheimer's Disease
    Senthil, Rethinam
    Srividya, S.
    Aruni, A. Wilson
    Basaran, Bahri
    Jyotsna
    Thirugnanasambandam, Rajendran
    INTERNATIONAL JOURNAL OF PEPTIDE RESEARCH AND THERAPEUTICS, 2020, 26 (04) : 1863 - 1870
  • [29] Low molecular weight glycosaminoglycan blockade of beta amyloid (25-35) induced neuropathology
    Walzer, M
    Lorens, S
    Hejna, M
    Fareed, J
    Mervis, R
    Hanin, I
    Cornelli, U
    Lee, JM
    MAPPING THE PROGRESS OF ALZHEIMER'S AND PARKINSON'S DISEASE, 2002, 51 : 165 - 170
  • [30] Five-mer peptides, inhibitor of amyloid-beta 25-35 aggregation, improve short-term memory deficits in amyloid-beta 25-35-induced Alzheimer's model mice
    Nakamura, Rina
    Higashi, Youichirou
    Konishi, Motomi
    Saito, Motoaki
    Akizawa, Toshifumi
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2023, 455